De Luca A - Search Results

1

The prognostic role of circulating tumor cells in lung cancer.

Normanno N, De Luca A, Gallo M, Chicchinelli N, Rossi A. Normanno N, et al. Among authors: de luca a. Expert Rev Anticancer Ther. 2016 Aug;16(8):859-67. doi: 10.1080/14737140.2016.1202767. Epub 2016 Jun 30. Expert Rev Anticancer Ther. 2016. PMID: 27337696 Review.

2

Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells.

De Luca A, Selvam MP, Sandomenico C, Pepe S, Bianco AR, Ciardiello F, Salomon DS, Normanno N. De Luca A, et al. Int J Cancer. 1997 Oct 9;73(2):277-82. doi: 10.1002/(sici)1097-0215(19971009)73:2<277::aid-ijc19>3.0.co;2-c. Int J Cancer. 1997. PMID: 9335455 Free article.

3

Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma.

Normanno N, De Luca A, Salomon DS, Ciardiello F. Normanno N, et al. Among authors: de luca a. Cancer Detect Prev. 1998;22(1):62-7. Cancer Detect Prev. 1998. PMID: 9466051 Review.

4

Apolipoprotein A-I reverse transcriptase-polymerase chain reaction analysis for detection of hematogenous colon cancer dissemination.

Normanno N, De Luca A, Castaldo A, Casamassimi A, Di Popolo A, Zarrilli R, Porcellini A, Acquaviva AM, Avvedimento VE, Pignata S. Normanno N, et al. Among authors: de luca a. Int J Oncol. 1998 Sep;13(3):443-7. doi: 10.3892/ijo.13.3.443. Int J Oncol. 1998. PMID: 9683776

5

De Luca A, Casamassimi A, Selvam MP, Losito S, Ciardiello F, Agrawal S, Salomon DS, Normanno N. De Luca A, et al. Int J Cancer. 1999 Feb 9;80(4):589-94. doi: 10.1002/(sici)1097-0215(19990209)80:4<589::aid-ijc17>3.0.co;2-d. Int J Cancer. 1999. PMID: 9935161 Free article.

6

Expression of cripto and amphiregulin in colon mucosa from high risk colon cancer families.

De Angelis E, Grassi M, Gullick WJ, Johnson GR, Rossi GB, Tempesta A, De Angelis F, De Luca A, Salomon DS, Normanno N. De Angelis E, et al. Among authors: de luca a, de angelis f. Int J Oncol. 1999 Mar;14(3):437-40. doi: 10.3892/ijo.14.3.437. Int J Oncol. 1999. PMID: 10024674

7

Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells.

Normanno N, Tortora G, De Luca A, Pomatico G, Casamassimi A, Agrawal S, Mendelsohn J, Bianco AR, Ciardiello F. Normanno N, et al. Among authors: de luca a. Oncol Rep. 1999 Sep-Oct;6(5):1105-9. doi: 10.3892/or.6.5.1105. Oncol Rep. 1999. PMID: 10425310

8

Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.

De Luca A, Pignata S, Casamassimi A, D'Antonio A, Gridelli C, Rossi A, Cremona F, Parisi V, De Matteis A, Normanno N. De Luca A, et al. Among authors: de matteis a. Clin Cancer Res. 2000 Apr;6(4):1439-44. Clin Cancer Res. 2000. PMID: 10778975

9

EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells.

Casamassimi A, De Luca A, Agrawal S, Stromberg K, Salomon DS, Normanno N. Casamassimi A, et al. Among authors: de luca a. Ann Oncol. 2000 Mar;11(3):319-25. doi: 10.1023/a:1008350811639. Ann Oncol. 2000. PMID: 10811499 Free article.

10

Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.

De Luca A, Arra C, D'Antonio A, Casamassimi A, Losito S, Ferraro P, Ciardiello F, Salomon DS, Normanno N. De Luca A, et al. Oncogene. 2000 Nov 30;19(51):5863-71. doi: 10.1038/sj.onc.1203979. Oncogene. 2000. PMID: 11127817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,186 results

Search Page